| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lisata Therapeutics, Inc. (LSTA) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 1 sell. LSTA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 332.0K | $1.06M | - | |
| Dir | 104.9K | $334.8K | - | |
| Dir | 95.8K | $305.7K | - | |
| Dir | 95.7K | $305.2K | - | |
| Dir | 95.4K | $304.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2015 | Vaters Robert S | President &CFO | Buy | 81,000 | $1.24 | $100,172.70 | +59.8% | |
| Mar 18, 2015 | Wei Eric | Director | Sell | 100,000 | $3.20 | $320,000.00 | -4.5% |